• Coptisine Modulates SIRT1 Ubiquitination to Alleviate PCOS i

  2026-05-14

  This study elucidates how Jiao-tai-wan (JTW) and its component coptisine ameliorate polycystic ovary syndrome (PCOS) through suppression of SIRT1 ubiquitination, impacting mitochondrial cholesterol import and ovarian steroidogenesis. Utilizing a DHEA-induced PCOS rat model, the findings reveal a targeted mechanism with potential translational value for PCOS research and therapy.

• Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4

  2026-05-14

  This study uncovers how berberine attenuates senescence-associated secretory phenotype (SASP)-related inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. The findings highlight a mechanistic link between berberine, ubiquitin-mediated GATA4/p62 degradation, and repression of chronic vascular inflammation, providing a new angle for targeting age-related cardiovascular disease.

• Lactate-Driven Ran Lactylation Regulates Astrocyte Polarizat

  2026-05-13

  This study uncovers a novel mechanism wherein lactate-induced lactylation of the Ran GTPase at lysine 123, regulated by SIRT1, promotes the polarization of astrocytes toward the neuroprotective A2 phenotype following oxygen-glucose deprivation/reoxygenation (OGD/R). These findings provide a mechanistic link between metabolic signaling and epigenetic regulation in the central nervous system, offering new research directions for spinal cord injury recovery.

• Cyclopamine as a Hedgehog Signaling Inhibitor: Workflows & I

  2026-05-13

  Cyclopamine, a potent Hedgehog signaling inhibitor from APExBIO, empowers precision assays in cancer research and developmental biology. This article demystifies optimized workflows, key protocol parameters, and troubleshooting tactics for probing pathway function, drawing on both recent comparative developmental studies and established best practices.

• G-1: Selective GPR30 Agonist Empowering Cardiovascular Model

  2026-05-12

  G-1, a selective GPR30 agonist, enables precise dissection of rapid estrogen signaling in cardiovascular, oncology, and immunology research. Its benchmark selectivity, robust DMSO solubility, and proven in vivo efficacy position it as an indispensable tool for translational and mechanistic studies.

• Apicidin: Precision Histone Deacetylase Inhibitor Workflows

  2026-05-12

  Apicidin is a powerful, selective histone deacetylase inhibitor enabling advanced epigenetic and toxicology research. This article delivers hands-on protocols, troubleshooting insights, and actionable guidance for maximizing Apicidin’s utility in cancer and reproductive models.

• Degarelix Acetate in Prostate Cancer: Study Findings and Res

  2026-05-11

  This article reviews the innovation and clinical impact of degarelix acetate, a third-generation GnRH antagonist for advanced prostate cancer. By preventing testosterone surges and offering rapid medical castration, degarelix addresses key limitations of earlier therapies, with comparative safety and efficacy established in pivotal trials.

• Tioconazole in Antifungal Research: Molecular Mechanisms & M

  2026-05-11

  Explore the advanced antifungal mechanism of Tioconazole and its integration into cutting-edge fungal infection models. This article reveals new research perspectives on the ergosterol biosynthesis pathway and assay optimization, providing a unique, in-depth resource for antifungal medication development.

• Oligomycin A: Redefining Mitochondrial Inhibition for Immuno

  2026-05-10

  Explore Oligomycin A as a mitochondrial ATP synthase inhibitor driving next-generation immunometabolic research. This article uniquely bridges recent discoveries in macrophage metabolic reprogramming with advanced assay design and protocol guidance.

• Cyclopamine: Epigenetic Intersections and Practical Innovati

  2026-05-09

  Explore Cyclopamine as a Hedgehog signaling inhibitor with unique focus on its epigenetic implications and advanced assay strategies. This article unveils practical and conceptual innovations for cancer research and developmental biology.

• Toremifene and STIM1: Precision Tools for Prostate Cancer Me

  2026-05-08

  Explore how Toremifene, a selective estrogen-receptor modulator, enables advanced, mechanism-driven prostate cancer research. This article uniquely bridges Toremifene’s molecular action with the STIM1-TSPAN18 axis, guiding assay strategy for metastasis studies.

• Macrophage EV-miR-660 Drives Breast Cancer Metastasis via NF

  2026-05-08

  This study reveals that tumor-associated macrophage (TAM)-derived extracellular vesicles (EVs) transfer microRNA-660 to breast cancer cells, promoting metastasis by downregulating KLHL21 and activating NF-κB signaling. The findings elucidate a specific molecular axis contributing to breast cancer progression and highlight potential translational research strategies targeting the tumor microenvironment.

• Omeprazole (A2845): Protocol and QC Guide for H+,K+-ATPase I

  2026-05-07

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor optimized for research on gastric acid secretion and antiulcer mechanisms. It is specifically suited for in vitro and preclinical workflows requiring high-purity, reproducible modulation of gastric acid formation. This product should not be used for diagnostic or therapeutic applications, and its insolubility in water/ethanol requires DMSO-based handling.

• CCCP Unlocks Mitochondrial Gradient Disruption for Biomarker

  2026-05-07

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is the gold-standard tool for precise, reproducible disruption of mitochondrial proton gradients. Leveraging insights from AI-driven biomarker discovery, this guide details robust workflows, troubleshooting, and advanced use-cases for CCCP in live-cell mitochondrial analysis.

• Kanamycin Sulfate: Water-Soluble Antibiotic in RNA Purificat

  2026-05-06

  Kanamycin Sulfate is not only a gold-standard water-soluble antibiotic for cell selection, but also pivotal in advanced workflows such as circular RNA purification and antibiotic resistance research. This article bridges bench protocols and troubleshooting strategies to empower scientists working at the intersection of microbiology and RNA therapeutics.

16492 records 1/1100 page Next 12345 下5页 Last page